Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling. My life has changed ...

点击蓝字关注我们【导读】非小细胞肺癌（Non-small cell lung cancer， ...

Datroway demonstrated durable antitumor activity and an acceptable safety profile in advanced NSCLC with actionable genomic ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

Lung Cancer in Non-Smokers: Clinicopathological and Survival Differences from Smokers - ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Lazcluze (lazertinib) for adults with non-small ...

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...

A recent study reveals that continuing immunotherapy beyond disease progression significantly improves survival rates in patients with advanced non-small cell and small cell lung cancers, particularly ...

Due to the physical, psychological, and socioeconomic consequences of a cancer diagnosis and treatment, people with cancer are especially vulnerable during extreme weather events like hurricanes, ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic ...

expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and previously untreated advanced melanoma patients. These two new indications bring the total indications ...